(Q35572277)

English

Demographics, Treatment Regimens and the Use of Angiotensin-Receptor Blockers in Heart Failure: Findings from the Valsartan Heart Failure Trial

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Demographics, treatment regimens and the use of angiotensin-receptor blockers in heart failure: findings from the Valsartan Heart Failure Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Demographics, Treatment Regimens and the Use of Angiotensin-Receptor Blockers in Heart Failure: Findings from the Valsartan Heart Failure Trial (English)

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

0 references

0 references

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

author name string

S. Majahalme

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14587301

27 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14587301

27 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/147323000303100501

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Journal of International Medical Research

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

351-361

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Trends in hospitalization for heart failure in Scotland 1980-1990.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Is the prognosis of heart failure improving?

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Diagnostic tests, treatment and follow-up in heart failure patients--is there a gender bias in the coherence to guidelines?

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Does gender bias exist in the medical management of heart failure?

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Relation between gender, etiology and survival in patients with symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Where are all the women with heart failure?

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

ABC of heart failure. History and epidemiology

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Diuretic use in the elderly: potential for diuretic-induced hypokalemia

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Aspirin and the treatment of heart failure in the elderly

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Congestive heart failure with preserved systolic function in a statewide sample of community hospitals

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Chronic heart failure in the United States: a manifestation of coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Predictors of target organ damage in hypertensive blacks and whites

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Association of body mass, gender and race with heart failure primarily due to hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Chymase-dependent angiotensin II forming systems in humans

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

The AT2 receptor: fact, fancy and fantasy

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100501

21 January 2018

Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure

3

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

British Journal of General Practice

4

46

77

author name string

Mair FS

publication date

1996

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

6

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Nutrition and the occurrence and prevention of cardiovascular disease in the elderly

15

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative

22

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study

24

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Schweizerische medizinische Wochenschrift

25

130

1192

author name string

Muntwyler J

publication date

2000

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

28

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

33

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges

39

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

41

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators

42

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

What is the optimal medical management of ischaemic heart failure?

44

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function

46

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

49

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

53

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Pharmacological Reviews

59

52

415

author name string

de Gasparo M

publication date

2000

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Functional and biochemical analysis of angiotensin II-forming pathways in the human heart

61

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

66

1 reference

10.1177/147323000303100501

https://api.crossref.org/works/10.1177/147323000303100501

27 March 2024

Identifiers

10.1177/147323000303100501

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35572277&oldid=2113545109"